Q&A: Physicians Weigh Improvements in MASLD Treatment Against Gaps in Assessment Strategies
Physician's Weekly
JUNE 24, 2025
In the next 5 to 10 years, we will likely learn which treatments are the most effective, safe, and sustainable,” Robert J. This is a well-done and concise summary of where we are in 2024 in trying to tackle the immense public health problem of MASLD.” Consider antiobesity medications, though they may not improve liver fibrosis.
Let's personalize your content